The weekly litigation news digest is live. Subscribe now

Anticancer Drug Containing Alpha, Alpha, Alphatrifluorothymidine And Thymidine Phosphorylase Inhibitor - EP1849470

The patent EP1849470 was granted to Taiho Pharmaceutical on Mar 20, 2024. The application was filed on Jan 25, 2006 under application number EP06712292A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP1849470

TAIHO PHARMACEUTICAL
Application Number
EP06712292A
Filing Date
Jan 25, 2006
Status
Patent Maintained As Amended
Feb 16, 2024
Publication Date
Mar 20, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKMar 21, 2018TER MEER STEINMEISTER & PARTNER -
STADA ARZNEIMITTELMar 21, 2018HAMM & WITTKOPP -

Patent Citations (2) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP0763529
OPPOSITIONWO2006080327

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents